Improving the lives of our patients.
We work tirelessly to create life changing treatments that help our patients live better and fuller lives.Learn More
Research & Development
We invest in innovative research and development through our own development or partnerships to best address the unmet needs of patientsLearn More
Through the acquisition of Agios Pharmaceuticals #oncology #business, we are proud to strengthen our portfolio in malignant hematology and solid tumors and expand our presence in the U.S.Learn More
Our CEO, David K. Lee, recently spoke with Luke Timmerman on his podcast, The Long Run, discussing how his upbringing influenced his desire to impact patient's lives directly, and how Servier is a different kind of pharmaceutical company.Learn More
Servier Completes Acquisition of Agios Pharmaceuticals' Oncology BusinessLearn More
Adobe Stock©Mat Hayward | Adobe Stock©REDPIXEL | Adobe Stock©Gorodenkoff | Adobe Stock©Monkey Business